• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型扎那米韦衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价

Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.

作者信息

Cheng Li Ping, Wang Tian Chi, Yu Rao, Li Meng, Huang Jin Wen

机构信息

School of Chemical and Environmental Engineering, Shanghai Institute of Technology, Shanghai 201418, China.

School of Chemical and Environmental Engineering, Shanghai Institute of Technology, Shanghai 201418, China.

出版信息

Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3622-3629. doi: 10.1016/j.bmcl.2018.10.040. Epub 2018 Oct 26.

DOI:10.1016/j.bmcl.2018.10.040
PMID:30389293
Abstract

Neuraminidase (NA) is an important antiviral drug target. Zanamivir is one of the most potent NA inhibitors. In this paper, a series of zanamivir derivatives as potential NA inhibitors were studied by combination of molecular modeling techniques including 3D-QSAR, molecular docking, and molecular dynamics (MD) simulation. The results show that the best CoMFA (comparative molecular field analysis) model has q = 0.728 and r = 0.988, and the best CoMSIA (comparative molecular similarity indices analysis) model has q = 0.750 and r = 0.981, respectively. The built 3D-QSAR models show significant statistical quality and excellent predictive ability. Seven new NA inhibitors were designed and predicted. 20 ns of MD simulations were carried out and their binding free energies were calculated. Two designed compounds were selected to be synthesized and biologically evaluated by NA inhibition and virus inhibition assays. One compound (IC = 0.670 µM, SI > 149) exhibits excellent antiviral activity against A/WSN/33 H1N1, which is superior to the reference drug zanamivir (IC = 0.873 µM, SI > 115). The theoretical and experimental results may provide reference for development of new anti-influenza drugs.

摘要

神经氨酸酶(NA)是一个重要的抗病毒药物靶点。扎那米韦是最有效的NA抑制剂之一。本文通过结合三维定量构效关系(3D-QSAR)、分子对接和分子动力学(MD)模拟等分子建模技术,研究了一系列作为潜在NA抑制剂的扎那米韦衍生物。结果表明,最佳的比较分子场分析(CoMFA)模型的q值为0.728,r值为0.988,而最佳的比较分子相似性指数分析(CoMSIA)模型的q值为0.750,r值为0.981。所构建的3D-QSAR模型显示出显著的统计学质量和出色的预测能力。设计并预测了7种新型NA抑制剂。进行了20纳秒的MD模拟,并计算了它们的结合自由能。选择两种设计的化合物进行合成,并通过NA抑制和病毒抑制试验进行生物学评估。一种化合物(IC = 0.670 μM,SI > 149)对A/WSN/33 H1N1表现出优异的抗病毒活性,优于参考药物扎那米韦(IC = 0.873 μM,SI > 115)。理论和实验结果可为新型抗流感药物的开发提供参考。

相似文献

1
Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.新型扎那米韦衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3622-3629. doi: 10.1016/j.bmcl.2018.10.040. Epub 2018 Oct 26.
2
Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.新型奥司他韦衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2017 Dec 15;27(24):5429-5435. doi: 10.1016/j.bmcl.2017.11.003. Epub 2017 Nov 4.
3
Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.含1,2,3-三唑的N-酰基扎那米韦类似物作为强效神经氨酸酶抑制剂的设计与合成
Eur J Med Chem. 2016 Nov 10;123:397-406. doi: 10.1016/j.ejmech.2016.07.064. Epub 2016 Jul 28.
4
Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.酰胍扎那米韦衍生物的合成及其作为神经氨酸酶抑制剂的活性评价。
Org Biomol Chem. 2013 Jun 28;11(24):3943-8. doi: 10.1039/c3ob40624e.
5
Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.作为强效抗流感药物的取代扎那米韦衍生物的分子建模与先导设计
BMC Bioinformatics. 2016 Dec 22;17(Suppl 19):512. doi: 10.1186/s12859-016-1374-1.
6
3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.三维定量构效关系和对接研究黄酮衍生物作为流感 H1N1 病毒神经氨酸酶的有效抑制剂。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5964-70. doi: 10.1016/j.bmcl.2011.07.071. Epub 2011 Jul 26.
7
Molecular dynamics directed CoMFA studies on carbocyclic neuraminidase inhibitors.基于分子动力学的碳环神经氨酸酶抑制剂的 CoMFA 研究。
Mol Divers. 2011 Nov;15(4):979-87. doi: 10.1007/s11030-011-9332-3. Epub 2011 Sep 16.
8
In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.白藜芦醇衍生物作为甲型H1N1流感病毒神经氨酸酶有效抑制剂的体外抗病毒作用及三维定量构效关系研究
Chem Biol Drug Des. 2015 Apr;85(4):427-38. doi: 10.1111/cbdd.12425. Epub 2014 Sep 29.
9
Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.通过分子动力学模拟和自由能计算深入了解 2009 年甲型流感(H1N1)神经氨酸酶 E119G 突变体对抗病毒药物的敏感性。
Antiviral Res. 2013 Nov;100(2):356-64. doi: 10.1016/j.antiviral.2013.09.006. Epub 2013 Sep 19.
10
Potential New H1N1 Neuraminidase Inhibitors from Ferulic Acid and Vanillin: Molecular Modelling, Synthesis and in Vitro Assay.潜在的新型 H1N1 神经氨酸酶抑制剂来源于阿魏酸和香草醛:分子模拟、合成和体外检测。
Sci Rep. 2016 Dec 20;6:38692. doi: 10.1038/srep38692.

引用本文的文献

1
Fluorescence paper sensor meets magnetic affinity chromatography: discovering potent neuraminidase inhibitors in herbal medicines.荧光纸传感器与磁性亲和色谱相结合:发现草药中的强效神经氨酸酶抑制剂。
Anal Bioanal Chem. 2025 Apr;417(9):1819-1832. doi: 10.1007/s00216-025-05761-y. Epub 2025 Jan 31.
2
Design, synthesis and inhibition evaluation of novel chalcone amide α-glucosidase inhibitors.新型查尔酮酰胺α-葡萄糖苷酶抑制剂的设计、合成与抑制活性评价。
Future Med Chem. 2024 Jul 2;16(13):1333-1345. doi: 10.1080/17568919.2024.2347092. Epub 2024 May 22.
3
Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022.
应对流感大流行的抗病毒化合物:2016-2022 年的最新进展。
Curr Med Chem. 2024;31(18):2507-2549. doi: 10.2174/0929867331666230907093501.
4
Recent progress in chemical approaches for the development of novel neuraminidase inhibitors.新型神经氨酸酶抑制剂开发的化学方法的最新进展。
RSC Adv. 2021 Jan 6;11(3):1804-1840. doi: 10.1039/d0ra07283d. eCollection 2021 Jan 4.
5
Direct access to various C3-substituted sialyl glycal derivatives from 3-iodo-sialyl glycals.从 3-碘代唾液酸糖基到各种 C3-取代的唾液酰基糖甘衍生物的直接途径。
Org Biomol Chem. 2021 Dec 1;19(46):10169-10173. doi: 10.1039/d1ob01977e.
6
Anti-Influenza Strategies Based on Nanoparticle Applications.基于纳米颗粒应用的抗流感策略
Pathogens. 2020 Dec 3;9(12):1020. doi: 10.3390/pathogens9121020.
7
Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial.奥司他韦与扎那米韦治疗慢性阻塞性肺疾病患者季节性流感病毒感染的疗效比较:一项随机对照试验。
Braz J Med Biol Res. 2020 Nov 27;54(2):e9542. doi: 10.1590/1414-431X20209542. eCollection 2020.